actavis.ie
Actavis Ireland-First Class Generic PharmaceuticalsActavis is one of the world’s leading player’s in the development, manufacture and sale of high-quality generic pharmaceuticals
http://www.actavis.ie/
Actavis is one of the world’s leading player’s in the development, manufacture and sale of high-quality generic pharmaceuticals
http://www.actavis.ie/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
6.4 seconds
PAGES IN
THIS WEBSITE
18
SSL
EXTERNAL LINKS
29
SITE IP
217.64.233.33
LOAD TIME
6.426 sec
SCORE
6.2
Actavis Ireland-First Class Generic Pharmaceuticals | actavis.ie Reviews
https://actavis.ie
Actavis is one of the world’s leading player’s in the development, manufacture and sale of high-quality generic pharmaceuticals
actavis.ie
Generic Pharmaceuticals- questions Actavis
http://www.actavis.ie/en/products
What is a generic medicine? A generic medicine is a medicine that is similar to an original brand medicine. It has the same active ingredient as the original medicine and is made to the same standard to make sure it is safe and effective. How do generic medicines become available? When a pharmaceutical company develops a new original medicine, it takes out a patent. The patent is a legal agreement that prevents other companies from making or selling the same medicine for a number of years. A generic medi...
Actavis Ireland Sales Team
http://www.actavis.ie/en/about/sales.htm
Martina joined Actavis in 2009 and is responsible for National key accounts. Martina can be contacted on 086 7816453. Key Account Manager (Hospital). Conor is responsible for working with and supporting Hospital Pharmacies throughout the country. Conor can be contacted on 086 0375953. Gregg joined Actavis in 2010 and is responsible for Independent Buying Groups and Regional Key Accounts. Gregg can be reached on 086 0238462.
Actavis Ireland-First Class Generic Pharmaceuticals
http://www.actavis.ie/en
First entered the Irish market in 2008 with just 15 products and a commitment to provide Irish retail and hospital pharmacists with long-term sustainable value across a broad product portfolio and outstanding customer service. This commitment based on a partnership approach with pharmacists has helped Actavis to grow to be a leading generic supplier with a portfolio of over 100 products (250 skus) across a range of therapeutic areas. Actavis Your Preferred Partner.
Generic Pharmaceuticals- questions Actavis
http://www.actavis.ie/en/products/faq.htm
What is a generic medicine? A generic medicine is a medicine that is similar to an original brand medicine. It has the same active ingredient as the original medicine and is made to the same standard to make sure it is safe and effective. How do generic medicines become available? When a pharmaceutical company develops a new original medicine, it takes out a patent. The patent is a legal agreement that prevents other companies from making or selling the same medicine for a number of years. A generic medi...
Actavis Medical Information/Query Form
http://www.actavis.ie/en/products/medical_information_form.htm
Please fill in all information as accurately as possible providing relevant details where required. Please note that the contact information provided in Section 1 will be used to allow Actavis to contact you with regard to your query. Please note that this information will not be passed on to any third party and information detailed in this form is treated as private and confidential. If you have trouble filling in this form please contact:. Email: medinfo@actavis.co.uk Tel: 0044 1271 385 257.
TOTAL PAGES IN THIS WEBSITE
18
Актавіс фармацевтична компанія
Станом на 03.08.2016 компанія Actavis Generics була придбана Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), провідною міжнародною фармацевтичною компанією, яка щоденно забезпечує мільйони пацієнтів високоякісними рішеннями, що орієнтовані на пацієнтів. Для отримання додаткової інформації відвідайте www.tevapharm.com. TEVA придбає Actavis Generics. Україна, 01032, Київ, бул. Т.Шевченка, 33, 10 поверх Тел.: (044) 569-80-20 факс (044) 569-80-18 www.actavis.com.ua.
Actavis Domů
Přípravky dodávané na trh v ČR. Krátkodobé přerušení dodávek na trh v ČR. Přípravky nedodávané na trh v ČR. 01 čvc 2015 / Produkt Změna distributora přípravků Refresh, Optive a Optive plus. 01 kvě 2015 / Jiné Actavis hrdým partnerem MS v hokeji 2015. Actavis, Inc. je globální integrovaná farmaceutická společnost zaměřená na vývoj, výrobu a prodej generických léků, brand produktů a biosimilars. Souhrn údajů o přípravcích a Příbalové informace. Podmínky přístupu na stránky.
Actavis Danmark - home
We are the New Actavis. A Global Leader in Generics. NYSE : ACT. ACT: En specialiseret medicinalvirksomhed i udvikling. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. Førende inden for generiske lægemidler på mere end 60 globale markeder. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. Førende inden for specialmærker henvendt til kvinder. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. Ekspansion af specialmærker på globale nøglemarkeder. Actavis A/S - ...
Actavis - Etusivu
We are the New Actavis. A Global Leader in Generics. NYSE : ACT. ACT: Lääkealan kasvava erityisosaaja. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. Actavis on johtava geneeristen valmisteiden tuottaja jo yli 60 maassa. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. Johtava naisten terveystuotteisiin erikoistunut yritys. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. Actavis markkinoi brändejään maailmanlaajuisesti. Masentaa - lääkettä vai terapiaa?
Nyitóoldal
We are the New Actavis. A Global Leader in Generics. NYSE : ACT. ACT: An Emerging Leader in Specialty Pharmaceuticals. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. A Generics Leader in 60 Global Markets. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. A Specialty Brands Leader in Women’s Health. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. Expanding Specialty Brands into Key Global Markets. Accelerating a Foundation in Biosimilars. Előrelátó K F be...
Actavis Ireland-First Class Generic Pharmaceuticals
We are the New Actavis. A Global Leader in Generics. NYSE : ACT. ACT: An Emerging Leader in Specialty Pharmaceuticals. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. A Generics Leader in 60 Global Markets. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. A Specialty Brands Leader in Women’s Health. We are the New Actavis. A Global Leader in Generics. NYSE : ACT. Expanding Specialty Brands into Key Global Markets. Accelerating a Foundation in Biosimilars.
Actavis - a global, integrated specialty pharmaceutical company - Actavis
Executive Officers and Directors. Internship and Co-op Programs. Pharm D Fellowship Program. Applying to Actavis in the US. Read the full story. Allergan Acquisition: Investor Information. Executive Officers and Directors. Actavis Launches Generic Lidoderm. A global specialty pharmaceutical leader. High priorities: sustainability and continual improvement. Actavis Completes Forest Laboratories Acquisition. The behaviors of all Actavis employees are defined by Our Winning Way. Applying to Actavis in the US.
Actavis - a global, integrated specialty pharmaceutical company - Actavis
Öryggi, heilsa, umhverfi. Test: /SEARCH /Widget-Documents Forsíða. Actavis eitt af 10 stærstu lyfjafyrirtækjum heims í kjölfar kaupa á Allergan. Fjölbreytt úrval bæði frumlyfja og samheitalyfja. Spennandi tækifæri hjá alþjóðlegu fyrirtæki. 11 maí 2015 Annað. Góð afkoma á fyrsta ársfjórðungi 2015. 17 mar. 2015 Annað. Actavis kaupir Allergan fyrir 70,5 milljarða dala. Dermatín er til meðferðar við sveppasýkingum í húð, dermatitis seborrhoeic ogflösu. Eitt af 10 stærstu lyfjafyrirtækjum heims.
Job-Support.dk - Præsentation af Actavis
Der er i øjeblikket ingen annoncerede ledige stillinger, men vi modtager altid gerne uopfordrede ansøgninger. Visit www.actavis.dk. To learn more about Actavis.
Actavis Japan
Actavis yra pasaulyje pirmaujanti farmacijos įmonė
Actavis misija ir vertybės. 2015 m. kovo 17 d. Actavis (NYSE: ACT) užbaigė Allergan įsigijimo sandorį. Naujoji kompanija veiklą vykdys daugiau nei 100 šalių. Kompanijos produktų portfelyje yra daugiau nei 1000 generinių, žinomų prekinių ženklų ir nereceptinių vaistų. Susijungusi kompanija yra trečia pagal dydį generinių vaistų gamintoja JAV bei patenka tarp 5 lyderiaujančias pozicijas užimančių vaistų gamintojų 20-yje tarptautinių rinkų. 18 KOV 2015 / Kita Actavis užbaigė Allergan įsigijimo sandorį.
